SYLVIA FLORES-BUGARIN: Open Payments
NPI 1215060884 · ADDISON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 38 payments from 6 companies in 2025. Trend: 2023 $74 · 2024 $408 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $316 |
| Novo Nordisk Inc | 10 | $226 |
| Intra-Sana Laboratories | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $17 |
Products named: Ozempic, UBRELVY, QULIPTA, Symbravo, LINZESS, RELTONE 200 MG, GLYCATE, NEFFY.
Industry payments across TX — which companies pay providers there.
